CDK7-IN-13

CDK7-IN-13

• CAS Number: 2765676-20-6
• UNSPSC Description: CDK7-IN-13 is a potent inhibitor of CDK7. CDK7-IN-13 is a pyrimidinyl derivative compound. CDK7-IN-13 has the potential for the research of various cancers, especially the cancer with transcriptional dysregulation (extracted from patent CN114249712A, compound 1)[1].
• Target Antigen: CDK
• Type: Reference compound
• Related Pathways: Cell Cycle/DNA Damage
• Applications: Cancer-Kinase/protease
• Field of Research: Cancer
• Assay Protocol: https://www.medchemexpress.com/cdk7-in-13.html
• Solubility: 10 mM in DMSO
• Smiles: CS(C)(=O)=NC1=CC=CC2=C1NC=C2C3=NC(N[C@H]4CCCNC4)=NC=C3C(F)(F)F
• Molecular Weight: 452.50
• References & Citations: [1]Guanpeng Qiu, et al. Pyrimidinyl derivatives, method for the production thereof and use thereof. Patent CN114249712A.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported